PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871188
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871188
The Global Flexible Endoscopic Surgery Robot Market was valued at USD 974.3 million in 2024 and is estimated to grow at a CAGR of 15.6% to reach USD 4.1 Billion by 2034.

Market growth is driven by the surging need for minimally invasive surgical tools, rapid advancements in robotic technology, and the growing number of surgical procedures worldwide. Flexible endoscopic surgery robots are transforming the healthcare landscape by offering hospitals, ambulatory centers, and other medical institutions advanced, precision-driven systems for minimally invasive treatments. These robotic solutions combine AI, imaging, and flexible robotic mechanisms to support both diagnostic and therapeutic functions, enhancing surgical precision and patient recovery. Progress in robotics, such as AI-enabled systems, high-definition visualization, and improved flexible arms, allows surgeons to perform complex interventions with higher accuracy and reduced risks. Additionally, the rise in global surgical procedures, spurred by an aging population and an increasing burden of chronic diseases, is further accelerating product demand. Continued investments in research and innovation, coupled with international expansion efforts by key manufacturers, are increasing accessibility and encouraging broader adoption of these systems in healthcare facilities.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $974.3 Million |
| Forecast Value | $4.1 Billion |
| CAGR | 15.6% |
In 2024, the therapeutic segment held a 58.2% share attributed to the rising acceptance of minimally invasive surgeries and enhanced precision in robotic control systems. The growing preference for robotic-assisted therapeutic interventions is reshaping the segment, offering improved visualization, superior dexterity, and refined navigation for intricate operations such as tumor excisions and tissue dissections with minimal trauma and faster patient recovery.
The urology application segment held a 41.3% share in 2024 and is projected to reach USD 1.7 Billion by 2034. Market growth in this domain is propelled by the increasing prevalence of urological disorders and the widespread integration of robotic-assisted surgeries that enhance surgical accuracy, reduce trauma, and shorten hospital stays. Technological advancements, including flexible robotic arms and AI-guided navigation systems, are significantly boosting precision in complex urological procedures and contributing to the market's rapid expansion.
North America Flexible Endoscopic Surgery Robot Market held 35.5% share in 2024, supported by the presence of leading industry participants such as Medtronic, Intuitive Surgical, and Johnson & Johnson. The region's dominance is further supported by a strong base of minimally invasive surgical procedures, favorable reimbursement frameworks, and active FDA support for robotic-assisted systems. The high prevalence of gastrointestinal and colorectal diseases, alongside the continuous focus on technological education and surgeon training, is fostering the swift adoption of flexible robotic platforms across hospitals and surgical centers.
Prominent companies active in the Global Flexible Endoscopic Surgery Robot Market include Intuitive Surgical, Medtronic, Johnson & Johnson, CMR Surgical, Asensus Surgical, Medrobotics, Endo Tools Therapeutics, Endotics, and GI View. To strengthen their position, key players in the Flexible Endoscopic Surgery Robot Market are adopting a mix of strategic initiatives aimed at driving innovation and expanding global reach. Companies are heavily investing in R&D to introduce next-generation robotic platforms equipped with AI-based precision tools and advanced imaging capabilities. Collaborative partnerships and strategic alliances are being formed to enhance technology integration and expand clinical applications. Firms are also focusing on obtaining regulatory approvals and developing comprehensive training programs to increase adoption rates among surgeons.